The WMA is proud to present this
2014 WebAward for Outstanding Achievement
in Web Development
Winning Entry: IMBRUVICA "The Storm Within"
Winner Name: Pharmacyclics Inc, Janssen Biotech Inc, Team Chemistry
Pharmacyclics, Inc, and Janssen Biotech, Inc, have partnered together in the development, marketing and promotion of IMBRUVICA® (ibrutinib), a recently approved, first-in-class therapy for the treatment of previously treated mantle cell lymphoma, previously treated chronic lymphocytic leukemia, and chronic lymphocytic leukemia with 17p deletion. Numerous clinical trials are underway to evaluate ibrutinib’s safety and efficacy in additional hematologic malignancies.